These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 32963002)

  • 1. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
    MacNair CR; Brown ED
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scope and Limitations of Exploiting the Ability of the Chemosensitizer NV716 to Enhance the Activity of Tetracycline Derivatives against
    Draveny M; Rose C; Pinet A; Ferrié L; Figadère B; Brunel JM; Masi M
    Molecules; 2023 May; 28(11):. PubMed ID: 37298737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New potentiators of ineffective antibiotics: Targeting the Gram-negative outer membrane to overcome intrinsic resistance.
    Klobucar K; Brown ED
    Curr Opin Chem Biol; 2022 Feb; 66():102099. PubMed ID: 34808425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Gram-negative bacterial infections by potentiation of antibiotics.
    Zabawa TP; Pucci MJ; Parr TR; Lister T
    Curr Opin Microbiol; 2016 Oct; 33():7-12. PubMed ID: 27232956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism between Rifampicin and Cationic Polyurethanes Overcomes Intrinsic Resistance of
    Tantisuwanno C; Dang F; Bender K; Spencer JD; Jennings ME; Barton HA; Joy A
    Biomacromolecules; 2021 Jul; 22(7):2910-2920. PubMed ID: 34085824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
    Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
    Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plantaricin A, Derived from Lactiplantibacillus plantarum, Reduces the Intrinsic Resistance of Gram-Negative Bacteria to Hydrophobic Antibiotics.
    Meng F; Liu Y; Nie T; Tang C; Lyu F; Bie X; Lu Y; Zhao M; Lu Z
    Appl Environ Microbiol; 2022 May; 88(10):e0037122. PubMed ID: 35499329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaching the Barrier: Quantifying Antibiotic Permeability across Gram-negative Bacterial Membranes.
    Cama J; Henney AM; Winterhalter M
    J Mol Biol; 2019 Aug; 431(18):3531-3546. PubMed ID: 30959052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-resistant bacteria: overcoming antibiotic permeability barriers of gram-negative bacteria.
    Savage PB
    Ann Med; 2001 Apr; 33(3):167-71. PubMed ID: 11370769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria.
    Farrag HA; Abdallah N; Shehata MMK; Awad EM
    J Biomed Sci; 2019 Sep; 26(1):69. PubMed ID: 31500622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic-in-Cyclodextrin-in-Liposomes: Formulation Development and Interactions with Model Bacterial Membranes.
    Vandera KA; Picconi P; Valero M; González-Gaitano G; Woods A; Zain NMM; Bruce KD; Clifton LA; Skoda MWA; Rahman KM; Harvey RD; Dreiss CA
    Mol Pharm; 2020 Jul; 17(7):2354-2369. PubMed ID: 32352791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphiphilic tribasic galactosamines potentiate rifampicin in Gram-negative bacteria at low Mg
    Mukherjee A; Ramirez D; Arora R; Arthur G; Schweizer F
    Bioorg Med Chem Lett; 2024 Jan; 97():129371. PubMed ID: 37301521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Biological Signature for the Inhibition of Outer Membrane Lipoprotein Biogenesis.
    Lehman KM; Smith HC; Grabowicz M
    mBio; 2022 Jun; 13(3):e0075722. PubMed ID: 35695460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin overcomes MCR-mediated colistin resistance in Gram-negative pathogens.
    Liu Y; Jia Y; Yang K; Tong Z; Shi J; Li R; Xiao X; Ren W; Hardeland R; Reiter RJ; Wang Z
    Theranostics; 2020; 10(23):10697-10711. PubMed ID: 32929375
    [No Abstract]   [Full Text] [Related]  

  • 16. A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier.
    Hart EM; Mitchell AM; Konovalova A; Grabowicz M; Sheng J; Han X; Rodriguez-Rivera FP; Schwaid AG; Malinverni JC; Balibar CJ; Bodea S; Si Q; Wang H; Homsher MF; Painter RE; Ogawa AK; Sutterlin H; Roemer T; Black TA; Rothman DM; Walker SS; Silhavy TJ
    Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21748-21757. PubMed ID: 31591200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Development of Pentamidine Analogs Identifies a Potent and Nontoxic Antibiotic Adjuvant.
    MacNair CR; Farha MA; Serrano-Wu MH; Lee KK; Hubbard B; Côté JP; Carfrae LA; Tu MM; Gaulin JL; Hunt DK; Hung DT; Brown ED
    ACS Infect Dis; 2022 Apr; 8(4):768-777. PubMed ID: 35319198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid crystalline bacterial outer membranes are critical for antibiotic susceptibility.
    Paracini N; Clifton LA; Skoda MWA; Lakey JH
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7587-E7594. PubMed ID: 30037998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of internal loop dynamics in antibiotic permeability of outer membrane porins.
    Vasan AK; Haloi N; Ulrich RJ; Metcalf ME; Wen PC; Metcalf WW; Hergenrother PJ; Shukla D; Tajkhorshid E
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35193963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery strategies to outer membrane targets in Gram-negative pathogens.
    Brown DG
    Bioorg Med Chem; 2016 Dec; 24(24):6320-6331. PubMed ID: 27178386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.